Since the beginning of the COVID-19 pandemic, reduced incidence of many viral and bacterial infections has been reported in children: bronchiolitis, varicella, measles, pertussis, pneumococcal and meningococcal invasive diseases. The purpose of this opinion paper is to discuss various situations that could lead to larger epidemics when the non-pharmaceutical interventions (NPI) imposed by the SARS-CoV-2…
Infectious Diseases Now Template
Write in a clean editor, then format for Infectious Diseases Now in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Infectious Diseases Now format
Infectious Diseases Now is a peer-reviewed journal published by Elsevier, covering Antibiotic Use and Resistance, COVID-19 Clinical Research Studies, Antibiotic Resistance in Bacteria.
| Publisher | Elsevier |
|---|---|
| Reference style | Numbered (Elsevier) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, C. Lee, A representative article title, Infectious Diseases Now 12 (2023) 45–58.
Formats any DOI in Infectious Diseases Now style. No sign-up. |
| Publishes research in | Antibiotic Use and Resistance COVID-19 Clinical Research Studies Antibiotic Resistance in Bacteria SARS-CoV-2 and COVID-19 Research Orthopedic Infections and Treatments |
| ISSN | 2666-9919 |
| Citation impact (2-yr) | 2.07 |
| h-index | 28 |
| i10-index | 110 |
| Total citations | 4,687 |
| Article processing charge | $1,640 |
| Top institutions publishing here | Inserm |
| Journal website | www.journals.elsevier.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Infectious Diseases Now per year
Citation impact of Infectious Diseases Now by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Infectious Diseases Now
OBJECTIVE: To characterize healthcare workers' (HCWs) intention to receive the COVID-19 vaccine by the beginning of the vaccine campaign in France. METHODS: Data were collected on a self-administered questionnaire through the website of a tertiary care center (February 9-18, 2021). RESULTS: Among 1,965 respondents, 1,436 (73.1%), 453 (23.1%), and 76 (3.9%) declared themselves in favor,…